drugset / Trial / NCT00002615

Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

NCT00002615

Phase 3 Completed 500 enrolled Medical Research Council
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not known whether receiving chemotherapy before surgery may be more effective than surgery alone in treating patients with stomach cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery plus combination chemotherapy with surgery alone in treating patients with stomach cancer.

Timeline

Start
1994-06
Primary completion
Completion
2003-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 60 mg/m2 Intravenous
Subject Epirubicin Small molecule 50 mg/m2 Intravenous
Subject fluorouracil Small molecule 200 mg/m2 Intravenous

Indications